Ribavirin
Cross-source consensus on Ribavirin from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Dosage & preparation
Comparisons
Evidence quality
Highlighted claims
- In SAFARI, ribavirin followed the Irrua regimen using intravenous loading and tapering daily doses across 10 days. — Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
- Ribavirin is used as standard care for Lassa fever in Nigeria, but its efficacy and risk-benefit profile remain uncertain because older pivotal studies have critical bias risk. — Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
- The Irrua ribavirin regimen differs from the older McCormick regimen by using a higher loading dose and lower later daily dosing. — Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
- Ribavirin pharmacokinetics in SAFARI were best described by a three-compartment model. — Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial